Finafloxacin
- TRADE NAME: Xtoro (Alcon)
- INDICATIONS: Acute otitis externa caused by susceptible strains of Pseudomonas aeruginosa and Staphylococcus aureus
- CLASS: Antibiotic, Antibiotic; fluoroquinolone, Antimicrobial
- HALF-LIFE: N/A
FDA APPROVAL DATE: 12/17/2014
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:None known
PREGNANCY CATEGORY: C
Please login to see the rest of this drug profile
CENTRAL NERVOUS SYSTEM.
GASTROINTESTINAL/HEPATIC.
LOCAL.
RESPIRATORY.
Page last updated 07/31/2023
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric